v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 18 $ 547
Prepaid expenses 16 112
Total current assets 34 659
Office and lab equipment, net of accumulated depreciation of $10 and $0 350 4
Intangible assets, net of accumulated amortization of $158 and $144 54 68
Goodwill 2,159
Other assets 3 3
Total assets 2,600 734
Current liabilities:    
Accounts payable 1,724 1,238
Accrued expenses 1,093 384
Convertible debentures, net of unamortized discount of $307 2,480
Derivative liability 3,338 2,541
Total current liabilities 8,635 4,163
Total liabilities 8,635 4,163
Commitments and contingencies
Stockholders' deficit:    
Convertible preferred stock, par value $.0001 per share; 30,000,000 shares authorized, 495 and 2,828 shares issued and outstanding, respectively
Common stock, par value $.0001 per share; 150,000,000 shares authorized, 9,075,589 and 1,398,832 shares issued and outstanding, respectively 1
Additional paid-in capital 48,425 45,391
Accumulated deficit (54,461) (48,820)
Total stockholders' deficit (6,035) (3,429)
Total liabilities and stockholders' deficit $ 2,600 $ 734

Source

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF LOSSES (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 384 $ 379 $ 1,349 $ 1,025
General and administrative 474 509 1,255 1,600
Total operating expenses 858 888 2,604 2,625
Loss from operations (858) (888) (2,604) (2,625)
Other income (expense):        
Gain on change in fair value of derivative liability 1,405 (334) 3,403 421
Gain on conversion of debt 39 39
Interest income (expense), net (5,017) 1 (6,479) 3
Loss before provision for income taxes (4,431) (1,221) (5,641) (2,201)
Provision for income taxes
Net loss $ (4,431) $ (1,221) $ (5,641) $ (2,201)
Net loss per common share, basic and diluted (in dollars per share) $ (0.69) $ (0.88) $ (1.77) $ (1.58)
Weighted average shares outstanding (in shares) 6,440,802 1,392,079 3,183,289 1,392,079

Source

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (5,641) $ (2,201)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 23 16
Stock-based compensation 179 70
Gain on change in fair value of derivative liability (3,403) (421)
Loss on sale of assets 4
Gain on conversion of debt (39)
Amortization of debt discount 13
Finance cost 6,463
Increase in operating assets:    
Prepaid expenses 100 (17)
Increase in operating liabilities:    
Accounts payable and accrued expenses 1,221 414
Cash used in operating activities (1,084) (2,135)
Cash flows from investing activities:    
Cash from acquisition 23
Proceeds from sale of assets 4
Acquisition of office equipment (3) (4)
Cash provided by investing activities 20
Cash flows from financing activities:    
Proceeds from convertible notes 250
Proceeds from sale of stock and warrants 285
Cash provided by financing activities 535
Net decrease in cash (529) (2,135)
Cash, beginning of period 547 2,465
Cash, end of period $ 18 $ 330

Source